Cargando…
A Systematic Study on the Optimal Nucleotide Analogue Concentration and Rate Limiting Nucleotide of the SARS-CoV-2 RNA-Dependent RNA Polymerase
The current COVID-19 pandemic has highlighted the necessity of more efficient antiviral compounds. The antiviral efficacy of adenosine-based analogs, the main repurposed drugs for SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibition, is mainly assessed through in vitro or cell-free polymerizati...
Autor principal: | Vatandaslar, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369030/ https://www.ncbi.nlm.nih.gov/pubmed/35955442 http://dx.doi.org/10.3390/ijms23158302 |
Ejemplares similares
-
Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
por: Ju, Jingyue, et al.
Publicado: (2020) -
Probing remdesivir nucleotide analogue insertion to SARS-CoV-2 RNA dependent RNA polymerase in viral replication
por: Romero, Moises E., et al.
Publicado: (2022) -
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase
por: Chien, Minchen, et al.
Publicado: (2020) -
Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication
por: Dejmek, Milan, et al.
Publicado: (2021) -
Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides
por: Wang, Bing, et al.
Publicado: (2021)